Active Not RecruitingNCT06805565
This study is active but not recruiting in Japan. It is testing ONO-1110 for anxiety.
AnxietyOtherFrom 18 Years to 65 Years
- Countries
- Japan
- Sponsor
- Ono Pharmaceutical Co., Ltd.
- Condition
- Anxiety
CompletedNCT03345342
This study is completed in the United States, in Australia, in France, .... It focuses on Schizophrenia.
SchizophreniaOtherFrom 18 Years to 70 Years
- Countries
- United States, Australia, France, ...
- Sponsor
- Janssen Research & Development, LLC
- Condition
- Schizophrenia
CompletedNCT02699086
This study is completed in the United States. It is testing PDC-1421 Treatment for ADHD.
ADHDOtherFrom 18 Years to 70 Years
- Countries
- United States
- Sponsor
- BioLite, Inc.
- Condition
- ADHD
TerminatedNCT00965419
This study has public registry information in the United States, in Canada, and in Taiwan. It focuses on ADHD.
ADHDOtherFrom 6 Years to 18 Years
- Countries
- United States, Canada, Taiwan
- Sponsor
- Eli Lilly and Company
- Condition
- ADHD
CompletedNCT00922636
This study is completed in the United States and in Canada. It focuses on ADHD.
ADHDOtherFrom 6 Years to 17 Years
- Countries
- United States, Canada
- Sponsor
- Eli Lilly and Company
- Condition
- ADHD
CompletedNCT03615794
This study is completed in the United States. It focuses on Depression.
Depression, Bipolarity, ...OtherFrom 18 Years to 50 Years
- Countries
- United States
- Sponsor
- Johns Hopkins University
- Condition
- Depression, Bipolarity, ...
CompletedNCT03866174
This study is completed in the United States. It is testing psilocybin for depression.
DepressionOtherFrom 21 Years to 65 Years
- Countries
- United States
- Sponsor
- Usona Institute
- Condition
- Depression
CompletedNCT03207048
This study is completed in China. It is testing repetitive Transcranial Magnetic Stimulation for Bipolarity.
BipolarityOtherFrom 18 Years to 60 Years
- Countries
- China
- Sponsor
- Guangzhou Psychiatric Hospital
- Condition
- Bipolarity
CompletedNCT01354353
This study is completed in the United States. It is testing safety and Tolerability for schizophrenia.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Denovo Biopharma LLC
- Condition
- Schizophrenia
Enrolling By InvitationNCT07000799
This study is enrolling by invitation in Norway. It is testing School Absenteeism and Student Well-being for Depression.
Depression, AnxietyBehavioralFrom 8 Years to 13 Years
- Countries
- Norway
- Sponsor
- University of Oslo
- Condition
- Depression, Anxiety
CompletedNCT07549581
This study is completed in the United States. It is testing SEP-380135 for depression.
Depression, Schizophrenia, ...OtherFrom 18 Years to 55 Years
- Countries
- United States
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Condition
- Depression, Schizophrenia, ...
WithdrawnNCT00458445
This study has public registry information in the United States. It is testing SPD465 for ADHD.
ADHDOtherFrom 19 Years to 25 Years
- Countries
- United States
- Sponsor
- Shire
- Condition
- ADHD